Re: Nasdaq listing [link]
Re: Nasdaq listing News on the way by the looks of it, Nasdaq listing or strategic investor will re rate this past 100p.Motif's peer on Nasdaq Paratek is 5 times the value of Motif.Senn.
Re: Nasdaq listing Josh likes it.. ( Beu )
Nasdaq listing Very interesting stock this, with the right partner and listing on Nasdaq i would expect a 2 bagger at least, news will be coming over the next few months in both i am led to believe from reading the last RNS from the company, also nice to be involved in a company helping saving lives.Senn.
Motif bio Looked at this mid Nov 25 % down since.was a placing july @ 50.why did it fall back ?
in Daily Mail Piece in Daily mail today. The disaster waiting to happen as antibiotics are becoming ineffective. Many routine operations will become impossible to conduct soon without new and innovative antibiotics. ROLL ON MOTIF!!pally
See company management present If you would like to see Graham Lumsden, CEO, present on behalf of Motif Bio, with the opportunity to ask him questions please follow the link below. The forum will be held on the 23rd of September from 5pm, registration is free.[link] presenting are Stadium Group and Ilika.Thanks,The Equity Development Team
good day today Thank goodness had a good rise today with more volume than usual???
price drop Why the slow price death?? AnybodyPally
Motif Bio's multi-billion dollar best-seller? Hospital can be a dangerous place. So-called "superbugs" - MRSA and Clostridium difficile in particular - are potentially fatal. About 300,000 people develop infections while being treated by the NHS every year. Nearly 50,000 die every year across Europe and the US because many antibiotics are now useless as bugs develop resistance. It's a problem which has reached crisis point.[link]
Re: PHASE 3 TRIALS! Further updates and BIG rises next week?
here is the Podcast [link] really does make for a good listenPally
webinar today?? Anybody have the link for that. Has it posted as a video by the company.Have sent them an email but have had no reply!!!Cheers Pally
Re: PHASE 3 TRIALS! Nasdaq listing could revalue MTFB many times more than the present valuation Ant comments from present shareholders
Webinar with CEO today at 1pm If you would like to hear Motif discuss their plans will be hosting a webinar with Graham Lumsden, CEO, today at 1pm. He will give a 25 minute presentation with an opportunity for Q&A at the end. If you would like to participate, please register now: [link] registering, you will receive a confirmation email containing information about joining the webinar.If you would like to submit any questions for management ahead of the meeting please send them to [email protected],The Equity Development Team